Notifications
The expansion observed in the wearable injectors market is primarily fueled by various factors, such as the increasing elderly population, the prevalence of chronic ailments, advancements in technology, and rising apprehension regarding needle stick injuries. These elements collectively contribute to the market's growth.
According to MarkNtel Advisors study, The Global Wearable Injectors Market size was valued at around USD 7.98 billion in 2023 & is estimated to grow at a CAGR of about 11.3% during the forecast period, i.e., 2025–30.
As approximately 463 million individuals globally are anticipated to receive a diabetes diagnosis in 2019, the demand for innovative methods of medication delivery is on the rise. Wearable injectors offer a promising solution with their precise dosing and user-friendly features, serving as a viable substitute for traditional syringes. By simplifying the process of insulin administration and enhancing adherence, wearable injectors are revolutionizing diabetes management, granting patients greater convenience and independence. This transformative capability aligns closely with the desires of individuals seeking autonomy and control over their health.
Traditional injections can often lead to feelings of discomfort and anxiety among patients; in contrast, wearable injectors provide a greater fantastic revel by way of replacing the pointy sting with a mild hum, allowing patients to pay attention to their fitness without being distracted by the technicalities of their remedy. Those wearable gadgets no longer only function as medicine dispensers; additionally, they double up as self-tracking equipment, simplifying the procedure of taking pictures and transferring information. As a result, the market for wearable injectors is expected to see considerable growth & expansion in the coming years.
Download Free Sample Copy @ https://www.marknteladvisors.com/query/request-sample/wearable-injectors-market.html
Key Findings in Wearable Injectors Market:
|
Historical Years |
2020-2023 |
|
Base Years |
2024 |
|
Forecast Years |
2025-2030 |
|
Key Report Highlights |
· Market Dimensions & Projections · Pricing Evaluation, · Recent Strategic Moves by Companies, · Primary Stakeholders, · Analysis of Import and Export Trends, · Competitive Landscape Assessment, · Emerging Opportunities, · Market Trends and Indicators |
|
Reports Delivery Format
|
Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 25 hours of the payment being successfully received, the report will be sent to your email address. |
Wearable Injectors Market Key Players:
Amgen Inc., Medtronic Plc, Insulet Corporation, Ypsomed, United Therapeutics Corporation, Subcuject, Enable Injections, Cequr Simplicity, Gerresheimer, Becton Dickinson & Company, West Pharmaceutical Services, Inc., Roche, Tandem Diabetes Services, Inc., Mannkind Corporation, Sonceboz, and others
Market Segmentation Overview:
By Type
-On-Body Injector
-Off-Body Injector
By Technology
-Spring-based Technology
-Motor-driven Technology
-Rotary Pump Technology
-Expanding Battery Technology
-Others
By Indication
-Diabetes
-Immuno-Oncology
-Cardiovascular Disease
-Chronic Pain
-Others
By End-User
-Hospitals & Clinics
-Home Care Settings
-Others
During the forecast period, the hospitals and clinics segment is expected to grow substantially in the Wearable Injectors Market. Wearable injectors are a valuable addition to hospitals, addressing the need for more effective drug delivery. They offer shorter injection times, streamlining workflows for nurses and medical staff to administer medication promptly and consistently. This increased efficiency not only minimizes costs but also allocates more crucial time for the care of patients. In hospital environments, the absence of doses can disrupt treatment plans and contribute to higher readmission rates. Hospitals are increasingly focusing on empowering patients to take control of their health through self-control and autonomy. Wearable injectors play a substantial role in this enterprise, permitting patients to independently administer their medicines, particularly for continual ailments requiring frequent dose changes.
Read Full Report @ https://www.marknteladvisors.com/research-library/wearable-injectors-market.html
By Region
Request Customization - https://www.marknteladvisors.com/query/request-customization/wearable-injectors-market.html
The Wearable Injectors Industry Recent Development:
2024: Ypsomed entered into a strategic partnership with ten23 Health to advance the commercialization of the YpsoDose wearable injector for the subcutaneous self-injection of large-volume doses.
About MarkNtel Advisors:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Being one of the most efficient market research companies in India, our specialized team of experienced & efficient market research professionals is capable of grasping every minute and valuable information & data of the market to offer our clients with satisfactory details. Our company has served the biggest market research firms in India at leading positions and is proficient in managing all types of market research projects.
Have an Any Query,
Call Us - US Office: +1 628 895 8081
Email - sales@marknteladvisors.com
Address Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
